SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-056058
Filing Date
2010-11-04
Accepted
2010-11-04 16:15:51
Documents
4
Period of Report
2010-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-20600_18k.htm 8-K 27930
2 EX-99.1 a10-20600_1ex99d1.htm EX-99.1 155921
3 GRAPHIC g206001mmi001.jpg GRAPHIC 1682
4 GRAPHIC g206001mmi002.jpg GRAPHIC 4318
  Complete submission text file 0001104659-10-056058.txt   193969
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19700 | Film No.: 101165143
SIC: 2834 Pharmaceutical Preparations